Source: GlobalData
China ophthalmic lasers market to grow at 4% CAGR through 2033, forecasts GlobalData
Posted in Medical Devices
The ophthalmic laser market in China is set for substantial growth, with a forecasted compound annual growth rate (CAGR) of approximately 4% through 2033. This growth is attributed to technological advancements in femtosecond and excimer lasers for refractive surgery, as well as a rising prevalence of eye diseases like myopia, reveals GlobalData, a leading data, and analytics company.
GlobalData’s report, “Ophthalmic Lasers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036,” reveals that in 2024, China accounted for around 25% of the Asia-Pacific (APAC) market, attributable to its swiftly expanding population affected by eye diseases such as myopia and substantial investments in advanced technology.
The National Medical Products Administration (NMPA) in China has recently approved the VISUMAX 800 with SMILE Pro software from ZEISS, featuring the femtosecond laser technology, that generates lenticule in under 10 seconds with an accelerated laser pulse repetition rate of 2 MHz. This advanced technology promises faster procedures, potentially leading to reduced recovery times and improved visual outcomes compared to traditional refractive surgery.
Shamreen Parween, Medical Devices Analyst at GlobalData, comments: “Traditional ophthalmic laser procedures have certain limitations, including a higher risk of complications, longer recovery times, and less predictable results. However, the advent of advanced laser techniques, coupled with hospital modernization, and increased R&D investment, is contributing to the increased accessibility and demand for advanced ophthalmic care.”
The ZEISS VISUMAX 800 further offers a smart, computer-assisted cyclotorsion and centration aid, providing enhanced precision and control during the procedures. Utilizing advanced technology, and shorter treatment durations, this system represents a significant leap forward in ophthalmic laser surgery.
Parween concludes: “The future of laser-based refractive surgery appears promising due to the advancements in personalized treatments, minimally invasive procedures, artificial intelligence integration, and enhanced accessibility. These developments are poised to improve precision, safety, and patient outcomes on a global scale. Consequently, this sector may garner increased investment from both the domestic and international stakeholders.”